🇮🇹 Italy Country × Condition
bladder cancer Clinical Trials in Italy
Active clinical trials for bladder cancer with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇮🇹 Italy
Active Trials in Italy (4)
NCT06992986
Recruiting
Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population
Enrollment
50 pts
Country
🇮🇹 Italy
Regina Elena Cancer Institute
View Trial → NCT06167356
Recruiting
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
Enrollment
20,000 pts
Country
🇮🇹 Italy
IRCCS San Raffaele
View Trial → NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Country
🇮🇹 Italy
UMC Utrecht
View Trial → NCT07403630
Recruiting
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
Enrollment
300 pts
Country
🇮🇹 Italy
Azienda Ospedaliero-Universitaria d...
View Trial → Frequently Asked Questions
How many bladder cancer clinical trials are active in Italy?
There are currently 4 active clinical trials for bladder cancer with sites in Italy, of which 4 are actively recruiting patients.
How can I join a bladder cancer clinical trial in Italy?
To join a bladder cancer clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are bladder cancer trials in Italy?
Active bladder cancer trials in Italy span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology